Rob Welner, Alana Franceski, Caroline Ennis, Daniel Phillips, Paran Goel
{"title":"1009 – BAD ALLIES: COEXISTING MUTANT CLONES REWIRE THE MARROW MICROENVIRONMENT TO PROMOTE EXPANSION","authors":"Rob Welner, Alana Franceski, Caroline Ennis, Daniel Phillips, Paran Goel","doi":"10.1016/j.exphem.2026.105505","DOIUrl":null,"url":null,"abstract":"<div><div>The progression of clonal hematopoiesis (CH) is shaped not only by cell-intrinsic mutational effects but also by cooperative signaling interactions among coexisting mutant clones that collectively remodel the bone marrow niche, alter cytokine landscapes, and reshape competitive fitness hierarchies in ways that fundamentally influence disease trajectory. Although clone size predicts clinical risk and <em>DNMT3A</em> and <em>TET2</em> mutations account for the majority of CH cases, the mechanisms by which coexisting clones interact to drive expansion remain poorly defined. Through the development of nonirradiated competitive transplant chimeras incorporating <em>Dnmt3a</em>-mutant and <em>Tet2</em>-deficient bone marrow under homeostatic conditions, introduced individually and in combination, three interconnected findings were identified: <em>Dnmt3a</em>-mutant clones exhibit modest, lineage-neutral expansion in isolation; <em>Tet2</em>-deficient clones expand robustly and promote myeloid output without increasing HSC frequency; and coexistence of both populations accelerates <em>Dnmt3a</em>-mutant clone expansion and induces distinct stem and myeloid phenotypes not observed when either clone competes alone. Mechanistically, single-cell transcriptomic analyses and bulk chromatin accessibility profiling reveal mutation-specific remodeling of cytokine-responsive transcriptional states and pathways governing stem cell persistence, consistent with <em>Tet2</em>-mutant cells reshaping the local signaling environment to lower response thresholds and potentiate expansion programs in neighboring <em>Dnmt3a</em>-mutant populations. These findings are being extended through analysis of multi-mutation CH cohorts to define how clonal composition influences inflammatory signaling and disease progression in human disease. It is proposed that CH evolution is governed less by the presence of individual mutations than by cooperative, niche-mediated crosstalk among coexisting clones, thereby establishing a framework in which clonal competition drives CH progression and identifying shared signaling dependencies as candidate targets to limit expansion and reduce transformation risk.</div></div><div>The progression of clonal hematopoiesis (CH) is shaped not only by cell-intrinsic mutational effects but also by cooperative signaling interactions among coexisting mutant clones that collectively remodel the bone marrow niche, alter cytokine landscapes, and reshape competitive fitness hierarchies in ways that fundamentally influence disease trajectory. Although clone size predicts clinical risk and <em>DNMT3A</em> and <em>TET2</em> mutations account for the majority of CH cases, the mechanisms by which coexisting clones interact to drive expansion remain poorly defined. Through the development of nonirradiated competitive transplant chimeras incorporating <em>Dnmt3a</em>-mutant and <em>Tet2</em>-deficient bone marrow under homeostatic conditions, introduced individually and in combination, three interconnected findings were identified: <em>Dnmt3a</em>-mutant clones exhibit modest, lineage-neutral expansion in isolation; <em>Tet2</em>-deficient clones expand robustly and promote myeloid output without increasing HSC frequency; and coexistence of both populations accelerates <em>Dnmt3a</em>-mutant clone expansion and induces distinct stem and myeloid phenotypes not observed when either clone competes alone. Mechanistically, single-cell transcriptomic analyses and bulk chromatin accessibility profiling reveal mutation-specific remodeling of cytokine-responsive transcriptional states and pathways governing stem cell persistence, consistent with <em>Tet2</em>-mutant cells reshaping the local signaling environment to lower response thresholds and potentiate expansion programs in neighboring <em>Dnmt3a</em>-mutant populations. These findings are being extended through analysis of multi-mutation CH cohorts to define how clonal composition influences inflammatory signaling and disease progression in human disease. It is proposed that CH evolution is governed less by the presence of individual mutations than by cooperative, niche-mediated crosstalk among coexisting clones, thereby establishing a framework in which clonal competition drives CH progression and identifying shared signaling dependencies as candidate targets to limit expansion and reduce transformation risk.</div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"162 ","pages":"Article 105505"},"PeriodicalIF":2.7000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental hematology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0301472X26001384","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/10/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The progression of clonal hematopoiesis (CH) is shaped not only by cell-intrinsic mutational effects but also by cooperative signaling interactions among coexisting mutant clones that collectively remodel the bone marrow niche, alter cytokine landscapes, and reshape competitive fitness hierarchies in ways that fundamentally influence disease trajectory. Although clone size predicts clinical risk and DNMT3A and TET2 mutations account for the majority of CH cases, the mechanisms by which coexisting clones interact to drive expansion remain poorly defined. Through the development of nonirradiated competitive transplant chimeras incorporating Dnmt3a-mutant and Tet2-deficient bone marrow under homeostatic conditions, introduced individually and in combination, three interconnected findings were identified: Dnmt3a-mutant clones exhibit modest, lineage-neutral expansion in isolation; Tet2-deficient clones expand robustly and promote myeloid output without increasing HSC frequency; and coexistence of both populations accelerates Dnmt3a-mutant clone expansion and induces distinct stem and myeloid phenotypes not observed when either clone competes alone. Mechanistically, single-cell transcriptomic analyses and bulk chromatin accessibility profiling reveal mutation-specific remodeling of cytokine-responsive transcriptional states and pathways governing stem cell persistence, consistent with Tet2-mutant cells reshaping the local signaling environment to lower response thresholds and potentiate expansion programs in neighboring Dnmt3a-mutant populations. These findings are being extended through analysis of multi-mutation CH cohorts to define how clonal composition influences inflammatory signaling and disease progression in human disease. It is proposed that CH evolution is governed less by the presence of individual mutations than by cooperative, niche-mediated crosstalk among coexisting clones, thereby establishing a framework in which clonal competition drives CH progression and identifying shared signaling dependencies as candidate targets to limit expansion and reduce transformation risk.
The progression of clonal hematopoiesis (CH) is shaped not only by cell-intrinsic mutational effects but also by cooperative signaling interactions among coexisting mutant clones that collectively remodel the bone marrow niche, alter cytokine landscapes, and reshape competitive fitness hierarchies in ways that fundamentally influence disease trajectory. Although clone size predicts clinical risk and DNMT3A and TET2 mutations account for the majority of CH cases, the mechanisms by which coexisting clones interact to drive expansion remain poorly defined. Through the development of nonirradiated competitive transplant chimeras incorporating Dnmt3a-mutant and Tet2-deficient bone marrow under homeostatic conditions, introduced individually and in combination, three interconnected findings were identified: Dnmt3a-mutant clones exhibit modest, lineage-neutral expansion in isolation; Tet2-deficient clones expand robustly and promote myeloid output without increasing HSC frequency; and coexistence of both populations accelerates Dnmt3a-mutant clone expansion and induces distinct stem and myeloid phenotypes not observed when either clone competes alone. Mechanistically, single-cell transcriptomic analyses and bulk chromatin accessibility profiling reveal mutation-specific remodeling of cytokine-responsive transcriptional states and pathways governing stem cell persistence, consistent with Tet2-mutant cells reshaping the local signaling environment to lower response thresholds and potentiate expansion programs in neighboring Dnmt3a-mutant populations. These findings are being extended through analysis of multi-mutation CH cohorts to define how clonal composition influences inflammatory signaling and disease progression in human disease. It is proposed that CH evolution is governed less by the presence of individual mutations than by cooperative, niche-mediated crosstalk among coexisting clones, thereby establishing a framework in which clonal competition drives CH progression and identifying shared signaling dependencies as candidate targets to limit expansion and reduce transformation risk.
期刊介绍:
Experimental Hematology publishes new findings, methodologies, reviews and perspectives in all areas of hematology and immune cell formation on a monthly basis that may include Special Issues on particular topics of current interest. The overall goal is to report new insights into how normal blood cells are produced, how their production is normally regulated, mechanisms that contribute to hematological diseases and new approaches to their treatment. Specific topics may include relevant developmental and aging processes, stem cell biology, analyses of intrinsic and extrinsic regulatory mechanisms, in vitro behavior of primary cells, clonal tracking, molecular and omics analyses, metabolism, epigenetics, bioengineering approaches, studies in model organisms, novel clinical observations, transplantation biology and new therapeutic avenues.